SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009446
Filing Date
2022-05-12
Accepted
2022-05-12 06:02:31
Documents
65
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ikna-20220331.htm   iXBRL 10-Q 2268168
2 EX-31.1 ikna-ex31_1.htm EX-31.1 20216
3 EX-31.2 ikna-ex31_2.htm EX-31.2 20307
4 EX-32.1 ikna-ex32_1.htm EX-32.1 20300
  Complete submission text file 0000950170-22-009446.txt   6987397

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ikna-20220331_def.xml EX-101.DEF 128334
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ikna-20220331_lab.xml EX-101.LAB 354684
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ikna-20220331_pre.xml EX-101.PRE 255261
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ikna-20220331_cal.xml EX-101.CAL 39989
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ikna-20220331.xsd EX-101.SCH 41927
59 EXTRACTED XBRL INSTANCE DOCUMENT ikna-20220331_htm.xml XML 1116721
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40287 | Film No.: 22915522
SIC: 2836 Biological Products, (No Diagnostic Substances)